
AbbVie (NYSE:ABBV) Trading 2% Higher Following Analyst Upgrade
AbbVie Inc. (NYSE:ABBV – Get Free Report) shares were up 2% during mid-day trading on Friday after Morgan Stanley raised their price target on the stock from $269.00 to $270.00. Morgan Stanley currently has an overweight rating on the stock. AbbVie traded as high as $225.82 and last traded at $223.50. Approximately 6,049,138 shares changed [...]










